Companies / Relay Therapeutics, Inc. / Activity

Activity — Relay Therapeutics, Inc.

12 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Marshall Wace, LLP
13F manager
NewCommon stock$9.37M+942K
941,825
0.43% of shares
medium
Q1 2026
as of
Arrowstreet Capital, Limited Partnership
13F manager
NewCommon stock$6.65M+668K
668,289
0.30% of shares
medium
Q2 2026
as of
Persistent Asset Partners Ltd
13F manager
NewCommon stock$1.32M+71K
70,693
0.03% of shares
low
Q4 2025
as of
Sanctuary Advisors, LLC
13F manager
NewCommon stock$1.20M+142K
142,228
0.06% of shares
low
Q1 2026
as of
Prelude Capital Management, LLC
13F manager
NewCommon stock$615.9K+62K
61,899
0.03% of shares
low
Q1 2026
as of
Mariner, LLC
13F manager
NewCommon stock$358.4K+36K
36,096
0.02% of shares
low
Q1 2026
as of
Nomura Holdings Inc
13F manager
NewCommon stock$248.8K+25K
25,000
0.01% of shares
low
Q1 2026
as of
Amundi
13F manager
NewCommon stock$212.7K+21K
21,381
<0.01% of shares
low
Q1 2026
as of
Prudential Financial Inc
13F manager
NewCommon stock$212.4K+21K
21,350
<0.01% of shares
low
Q2 2025
as of
Sanctuary Advisors, LLC
13F manager
NewCommon stock$202.9K+59K
58,654
0.03% of shares
low
Q1 2026
as of
Gabelli Funds LLC
13F manager
NewCommon stock$119.4K+12K
12,000
<0.01% of shares
low
Q2 2026
as of
Meeder Asset Management Inc
13F manager
NewCommon stock$62.3K+3K
3,332
<0.01% of shares
low
← PrevPage 1 of 1Next →